The Effect of IV Cangrelor and Oral Ticagrelor Study

NCT02733341 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Coronary Syndrome (ACS)
High On-treatment Platelet Reactivity (HTPR)
Microvascular Obstruction (MVO)
ST-segment Elevation Myocardial Infarction (STEMI)
Thrombolysis in Myocardial Infarction (TIMI)
Unstable Angina (UA)

Interventions

DRUG: Cangrelor
DRUG: Ticagrelor

Sponsor

The Royal Wolverhampton Hospitals NHS Trust